Top Players Shaping the Restorative Dentistry Market: An In-Depth Analysis

Healthcare News

Apr 4, 2023 • 3 min read

The global restorative dentistry market is projected to reach USD 22.2 billion by 2027 from USD 16.5 billion in 2022, at a CAGR of 6.1% from 2022 to 2027. The growth of the global restorative dentistry market is driven by a growing number of tooth repair procedures, rising demand for advanced cosmetic dental procedures, growing market for dental tourism in emerging countries, development of technologically advanced solutions, and lifestyle changes & unhealthy food habits. However, factors such as high costs of dental implants and limited reimbursements may restrain market growth to a certain extent during the forecast period.

The global restorative dentistry market are Institut Straumann AG (Switzerland), Envista Holdings Corporation (US), Dentsply Sirona (US), Zimmer Biomet Holding Inc. (US), 3M Company (US), COLTENE Group (Switzerland), Mitsui Chemicals (Japan), GC Corporation (Japan), Septodont Holding (France), Ivoclar Vivadent (Liechtenstein), VOCO GmbH (Germany), BEGO GmbH & Co. KG (Germany), DMG Chemisch-Pharmazeutische Fabrik (Germany), Henry Schein, Inc. (US), Keystone Dental Inc. (US), DiaDent (South Korea), Ultradent Products (US), Kuraray Noritake Dental (Japan), Brasseler USA (US), SHOFU INC. (Japan), SDI Limited (Australia), Zhermack SpA (Italy), DENTAURUM GmbH & Co. KG (Germany), BISCO, Inc. (US), and Dental Technologies Inc. (US). These companies adopted strategies such as acquisitions, partnerships, expansions, and product launches to enhance their presence in the restorative dentistry market.

Dentsply Sirona (US) accounted for 20-25% of the restorative dentistry market in 2021. The company primarily focuses on inorganic strategies such as acquisitions and expansions to maintain its position in the market. For instance, in January 2021, it acquired two companies (Datum Dental and Byte) in the restorative dentistry market to expand its reach globally. New advancements in technology are also anticipated to significantly influence the product portfolio in dentistry and selective areas of healthcare. As a result, the company pursues R&D initiatives to support this product development, including collaborations with external research institutions, dental and medical schools. The company directly invests in developing new products, improving existing products, and advances in technology through collaborations with research centers and other research institutions.

Institut Straumann AG (Germany) held the leading position in the global restorative dentistry market with a share of 10-15% in 2021. The company has a diversified product portfolio of dental consumables systems (implant systems), which include a wide range of tools for the treatment of dental procedures. Over the years, the company has developed innovative products for various medical applications. In May 2020, the company launched its Straumann Zygomatic implant that features the advantages of Straumann’s BLX and BLT implant prosthetic range for fixed overdentures. Furthermore, to strengthen its market position, the company focuses on increasing its R&D spending in dental technology to develop a strong product portfolio. The company has a strong manufacturing and distribution footprint worldwide, enabling it to serve customers in the Americas, Africa, Europe, the Middle East, and the Asia Pacific.

Opportunities: Increasing investments in CAD/CAM technologies

Computer-aided design (CAD) and computer-aided manufacturing (CAM) are increasingly being adopted by the dental industry due to the increased precision offered by these technologies for dental restoration and digital orthodontics. These technologies are used to develop milled crowns, dentures, bridges, and fabricated abutments used in dental restoration procedures. Also, personalised brackets and removable braces in orthodontic treatments are designed using CAD/CAM technologies. The increasing use of CAD/CAM has also reduced the need to wear temporary bridges and crowns during dental restoration treatments, enabled less time-consuming treatment procedures, and reduced the number of doctor visits.

According to the American Academy of Cosmetic Dentistry (AACD), in 2017, 34% of surveyed practises in the US reported using chairside CAD/CAM, up from 28% in 2015. Among the practises without a chairside CAD/CAM, 32% consider future purchases. However, most prosthetic elements are still made manually, and the use of CAD/CAM associated with restorative dental products is increasing due to its advantages. Although most prosthetic elements are still manufactured manually, CAD/CAM prosthetic elements are increasing due to the advantages of CAD/CAM over conventional technologies. Also, CAD/CAM offers significant advantages in customising dental prosthetics. The shift towards digitalization also encourages dental product manufacturers to invest more in CAD/CAM technologies.

Sign up for more like this.